Defence Therapeutics Inc. | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Headlines Articles Press releases Defence Therapeutics Inc.

Home
Companies
Defence Therapeutics Inc.

BRIEF

published on 08/19/2024 at 16:05, 4 months 2 days ago

Defence Therapeutics explore l'hydrogel Accum® pour l'administration de GLP-1

Thérapeutique De Défense Produits Biopharmaceutiques Traitement De L'obésité Agonistes Du GLP-1 Technologie Accum®
BRIEF

published on 08/19/2024 at 16:05, 4 months 2 days ago

Defence Therapeutics Explores Accum® Hydrogel for GLP-1 Delivery

Obesity Treatment Biopharmaceuticals Defence Therapeutics GLP-1 Agonists Accum® Technology
PRESS RELEASE

published on 08/19/2024 at 16:00, 4 months 2 days ago

DEFENCE INVESTIGATES THE APPLICATION OF THE ACCUM® HYDROGEL TECHNOLOGY TO DELIVER GLP-1 IN ORDER TO INCREASE THE TREATMENT EFFICACY OF DIABETES AND WEIGHT LOSS
Defence Therapeutics Inc. explores using Accum® Hydrogel technology to enhance GLP-1 treatment for diabetes & weight loss. GLP-1 drugs aim to tackle obesity & comorbidities, amid growing global health challenges

Weight Loss Diabetes Treatment Defence Therapeutics Inc. GLP-1 Accum® Hydrogel Technology
BRIEF

published on 08/13/2024 at 08:35, 4 months 8 days ago

Defence Therapeutics partners with Orano for Advanced Cancer Radio-Immunotherapy

Cancer Defence Therapeutics Radio-Immunotherapy Orano RIC
BRIEF

published on 08/13/2024 at 08:35, 4 months 8 days ago

Defence Therapeutics s'associe à Orano pour la radio-immunothérapie contre le cancer avancé

Cancer Thérapeutique De Défense Orano RIC Radio-immunothérapie
PRESS RELEASE

published on 08/13/2024 at 08:30, 4 months 8 days ago

DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES
Defence Therapeutics collaborates with Orano to develop targeted radio-immunotherapy for cancer, aiming to advance treatment efficacy with novel technology

Partnership Cancer Treatment Defence Therapeutics Radio-Immunotherapy Orano
BRIEF

published on 07/24/2024 at 08:05, 4 months 28 days ago

Defence Therapeutics Granted CNRI-H from Canadian Nuclear Laboratories

Cancer Research Defence Therapeutics CNRI-H Radio-immuno-conjugates HER2-positive Cancer
BRIEF

published on 07/24/2024 at 08:05, 4 months 28 days ago

Defence Therapeutics obtient le CNRI-H des Laboratoires Nucléaires Canadiens

Recherche Contre Le Cancer Thérapeutique De Défense CNRI-H Radio-immunoconjugués Cancer HER2-positif
PRESS RELEASE

published on 07/24/2024 at 08:00, 4 months 28 days ago

DEFENCE THERAPEUTICS GRANTED CNRI-H FROM THE CANADIAN NUCLEAR LABORATORIES TO ACCELERATE THE DEVELOPMENT OF ITS RADIO-IMMUNO-CONJUGATES PROGRAM
Defence Therapeutics granted CNRI-H from the Canadian Nuclear Laboratories to accelerate the development of its radio-immuno-conjugates program

Biopharmaceutical Defence Therapeutics CNRI-H Canadian Nuclear Laboratories Radio-immuno-conjugates Program
BRIEF

published on 07/08/2024 at 08:05, 5 months 13 days ago

Defence Therapeutics ne reçoit aucune objection de Santé Canada pour un essai sur le mélanome

Essai De Phase I Thérapeutique De Défense Santé Canada AccuTOX Mélanome

1 2 ... 8

Accesswire

Published on 12/21/2024 at 01:30, 18 hours 4 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 18 hours 4 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 29 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 34 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 20 hours 4 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 43 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 49 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 16 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 16 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE